News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Helix BioMedix, Inc. (HXBM) Reports Third Quarter 2011 Results



11/4/2011 7:44:25 AM

BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCQB: HXBM), a developer of bioactive peptides, today announced financial results for the company’s third quarter ended September 30, 2011.

Third Quarter 2011 Highlights

•Revenue for the third quarter of 2011 increased by 321% to $395,000, compared to $94,000 for the same period in 2010.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES